---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-004104"
form_type: "8-K"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2025-01-29T23:59:59+00:00"
generated_at: "2026-05-27T06:50:36.436564+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Glucotrack CFO James Cardwell resigns; Peter Wulff appointed as CFO

## Summary
- James Cardwell resigned as CFO effective Jan 27, 2025; will remain as consultant for transition.
- Peter Wulff appointed CFO effective Jan 28, 2025; has 40+ years life sciences finance experience.
- Wulff's base salary: $300k for 2025, $450k thereafter; eligible for bonuses tied to financing milestones up to $262.5k total.
- Initial equity grant of options for 1.25% of outstanding common stock under 2024 Equity Incentive Plan.
- Wulff most recently CFO at Biological Dynamics; previously CFO at JenaValve Technology.

## SEC filing metadata
- accession: 0001493152-25-004104
- form_type: 8-K
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2025-01-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000149315225004104/0001493152-25-004104-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000149315225004104/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-004104
- JSON: https://secwatch.observer/filing/0001493152-25-004104.json
- Plain text: https://secwatch.observer/filing/0001493152-25-004104.txt

## Key facts
- Executive change
  James Cardwell resigned as Chief Financial Officer at Glucotrack, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On January 27, 2025, James Cardwell informed the Board of Directors (the “Board”) of Glucotrack, Inc. (the “Company”) that he was resigning as Chief Financial Officer of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506983/000149315225004104/0001493152-25-004104-index.htm
- Executive change
  Peter C. Wulff was appointed as Chief Financial Officer at Glucotrack, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: In connection with Mr. Cardwell’s resignation, on January 28, 2025, the Board appointed Peter C. Wulff as Chief Financial Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506983/000149315225004104/0001493152-25-004104-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.